COM-B-based holistic rehabilitation and psychological care on postoperative headache dizziness and depression in hypertensive intracerebral hemorrhage patients

Table 1 Comparison of general information between the two groups of patients, n (%)

Variable	Control group (n = 50)	Observation group (n = 50)	χ2/t	P value
Gender			0.226	0.635
Male	29 (58.00)	27 (54.00)
Female	21 (42.00)	23 (46.00)
Age (year), mean ± SD	55.91 ± 6.19	56.07 ± 6.23	0.152	0.880
Marriage			1.841	0.398
Unmarried	3 (6.00)	2 (4.00)
Married	43 (86.00)	45 (90.00)
Divorced or widowed	4 (8.00)	3 (6.00)
Education level			4.703	0.095
Primary school and below	10 (18.00)	12 (24.00)
Junior high to high school	29 (58.00)	31 (62.00)
College degree or above	11 (24.00)	7 (14.00)
Duration of hypertension (in years), mean ± SD	6.78 ± 1.37	6.85 ± 1.44	0.314	0.754
Cerebral hemorrhage volume (mL), mean ± SD	43.55 ± 6.07	43.70 ± 6.11	0.086	0.931

Table 2 Comparison of headache scores between the two groups, mean ± SD

Group	VAS (points)		Headache duration (minutes)		Frequency of headaches (minutes)
	Before treatment	After treatment	Before treatment	After treatment	Before treatment	After treatment
Control group (n = 50)	6.83 ± 1.08	2.37 ± 0.66a	4.15 ± 1.23	2.06 ± 0.44a	4.84 ± 0.59	2.84 ± 0.61a
Observation group (n = 50)	6.91 ± 1.11	2.08 ± 0.47a	4.20 ± 1.16	1.88 ± 0.51a	4.77 ± 0.55	2.43 ± 0.49a
t	0.058	2.144	0.193	2.384	0.994	2.569
P value	0.953	0.034	0.848	0.018	0.322	0.012

^aP < 0.05 vs the pre-treatment values in this group.

VAS: Visual analog scale.

Table 3 Comparison of vertigo scores between the two groups, mean ± SD

Group	DARS (points)		DHI (points)
	Before treatment	After treatment	Before treatment	After treatment
Control group (n = 50)	35.21 ± 4.68	27.94 ± 4.14a	70.22 ± 8.91	62.54 ± 7.31a
Observation group (n = 50)	35.30 ± 4.64	25.60 ± 4.06a	70.40 ± 8.84	59.25 ± 7.06a
t	0.369	3.499	0.014	2.857
P value	0.713	0.001	0.989	0.005

^aP < 0.05 vs the pre-treatment values in this group.

DARS: Dizziness Assessment Rating Scale; DHI: Dizziness Handicap Inventory.

Table 4 Comparison of depression and sleep quality scores between the two groups of patients, mean ± SD

Group	SDS (points)		PSQI (points)
	Before treatment	After treatment	Before treatment	After treatment
Control group (n = 50)	53.03 ± 5.04	46.80 ± 4.33a	13.05 ± 2.67	8.59 ± 2.04a
Observation group (n = 50)	53.11 ± 4.91	43.21 ± 4.14a	12.96 ± 2.55	6.84 ± 1.64a
t	0.524	4.570	0.706	4.750
P value	0.601	< 0.001	0.482	< 0.001

^aP < 0.05 vs the pre-treatment values in this group.

SDS: Self-Rating Depression Scale; PSQI: Pittsburgh Sleep Quality Index.

Table 5 Comparison of neurological function, motor function, and daily living activities between the two groups of patients, mean ± SD

Group	NIHSS (points)		FMA (points)		BI (points)
	Before treatment	After treatment	Before treatment	After treatment	Before treatment	After treatment
Control group (n = 50)	27.51 ± 3.57	17.77 ± 4.28a	35.48 ± 5.19	58.64 ± 6.11a	47.50 ± 5.48	64.94 ± 5.69a
Observation group (n = 50)	27.72 ± 3.64	13.47 ± 4.67a	35.60 ± 5.06	63.12 ± 5.79a	47.39 ± 5.41	68.36 ± 6.08a
t	0.678	5.802	0.002	4.193	0.182	3.481
P value	0.499	< 0.001	0.998	< 0.001	0.856	0.001

^aP < 0.05 vs the pre-treatment values in this group.

NIHSS: National Institutes of Health Stroke Scale; FMA: Fugl-Meyer Assessment; BI: Barthel Index.